Related Experiment Videos
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic
L S Forno1, L E DeLanney, I Irwin
1DVA Medical Center, Palo Alto, California 94304.
Abstract:
The MPTP monkey model for PD has continued to display similarities as well as differences from the human disease, also in respect to its neuropathology. In 65 MPTP-treated squirrel monkeys with survival for more than 2 days, the main similarities consisted of nerve cell degeneration, not only of SN, but also, in the majority of cases, of the LC. In 13 animals that survived for from 1 to 7 years after their first exposure to MPTP, the nerve cells in the ventrolateral portion of the SN compacta were particularly vulnerable, just as in PD. The principal differences were the lack of progression of the disease process in these long-term animals (although this has yet to be systematically tested) and the absence of formation of typical Lewy bodies in the SN, LC, and other predilection sites for Lewy bodies. Since inclusion bodies, now observed in 16 monkeys, could be produced fairly consistently in aged MPTP-treated squirrel monkeys, they appeared to represent a bridge between these similarities and differences. They had some features, especially their location in predilection sites for Lewy bodies, such as the SN, in common with Lewy bodies, but did not display the fully convincing morphological and immunocytochemical features, characteristics of the human inclusion bodies in PD. Overall, these studies continue to provide tantalizing hints that this model could lead to important new insights into the pathologic process that underlies PD.
Insights
The MPTP monkey model shows similarities and differences to Parkinson's disease (PD) neuropathology. Inclusion bodies observed in monkeys may bridge these distinctions, offering insights into PD's pathological process.
Area of Science:
- Neuroscience
- Neuropathology
- Animal Models
Background:
- The MPTP monkey model is utilized to study Parkinson's disease (PD).
- This model exhibits both similarities and differences compared to human PD neuropathology.
Purpose of the Study:
- To investigate the neuropathological similarities and differences between MPTP-treated monkeys and human PD.
- To evaluate the utility of inclusion bodies in MPTP-treated monkeys as a bridge between observed similarities and differences.
Main Methods:
- MPTP was administered to squirrel monkeys.
- Neuropathological examination was performed on monkeys with varying survival times post-MPTP exposure.
- Inclusion bodies were analyzed for morphological and immunocytochemical features.
Main Results:
- MPTP-treated monkeys showed nerve cell degeneration in the substantia nigra (SN) and locus coeruleus (LC), similar to PD.
- Long-term survivors exhibited vulnerability in the SN compacta, mirroring PD.
- Typical Lewy bodies were absent, but inclusion bodies were observed in aged monkeys.
- These inclusion bodies shared some features with Lewy bodies but lacked definitive morphological and immunocytochemical characteristics.
Conclusions:
- The MPTP monkey model presents valuable similarities to PD neuropathology, particularly in neuronal degeneration.
- The absence of Lewy bodies and presence of inclusion bodies highlight key differences from human PD.
- Inclusion bodies may serve as a transitional feature, warranting further investigation into PD's pathological mechanisms.